Navigation Links
Local Head-Injury Patients Sought for Study Investigating Potential Treatment for Daytime Sleepiness

KING OF PRUSSIA, Pa., Jan. 12 /PRNewswire/ -- Local patients are being sought for a national clinical research study currently investigating a study medication for people who have had a head injury, concussion or bump on the head and feel sleepy or tired during the day.  According to the Centers for Disease Control and Prevention, head injury is one of the most common neurologic disorders, affecting around 1.5 million Americans every year. Many people with a past head injury feel sleepy during the day, yet few people know that their sleepiness might be connected to this injury.  People experiencing daytime sleepiness who have had one head injury within the last 10 years are encouraged to contact the clinical research screening center at 1-877-674-6317 or go to for more information and where they can take the pre-screening questionnaire to see if they are eligible for the study.

"Currently, there are no treatments for patients who suffer from sleepiness during the day as a result of head injury," according to study investigator Dr. Milton Erman, MD at Avastra Clinical Trials. "Consequently, there is a great need for new medicines to treat this life-changing problem."

The clinical study is specifically designed for adults aged 18 to 65 who have had a head injury, concussion, or bump on the head within the last 10 years and feel sleepy or tired during the day. It will examine different dosage strengths of the study medicine and how patients respond to them. Eligible participants may receive medical care related to the study at no cost and be reimbursed for time and travel as a result of taking part in the trial.

A recent online survey of more than 100 people who have had a previous head injury found that feeling sleepy during the day negatively affects their work and family life. The survey was conducted by MediciGlobal, a patient communications firm working with Cephalon, Inc., the biopharmaceutical company sponsoring the study.

"Seventy percent of head injury sufferers surveyed said that their daytime sleepiness affects their ability to effectively interact with their family and co-workers, and seriously impacts long-term relationships," said Dr. Erman.  "This study is important because daytime sleepiness can negatively impact the daily lives of so many patients suffering from head injuries."

About the Study Sponsor

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology.

SOURCE MediciGlobal



SOURCE MediciGlobal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
2. Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption
3. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Local Research Foundation Achieves Milestone in Fight Against Cancer
6. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
7. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
8. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
9. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
10. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
11. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):